| ASSET | YEAR | % RETURN |
|---|---|---|
Torm PLC Class A (TRMD) | 2022 | 294.68% |
Verona Pharma PLC ADR (VRNA) | 2022 | 284.83% |
Tidewater (TDW) | 2022 | 244.39% |
Madrigal Pharmaceuticals (MDGL) | 2022 | 238.09% |
TransMedics (TMDX) | 2022 | 221.29% |
PBF Energy (PBF) | 2022 | 211.45% |
Vista Oil Gas ADR (VIST) | 2022 | 195.47% |
Rhythm Pharmaceuticals (RYTM) | 2022 | 191.2% |
ADMA Biologics (ADMA) | 2022 | 177.14% |
Catalyst Pharmaceuticals (CPRX) | 2022 | 173.93% |
Transportadora de Gas del Sur SA ADR (TGS) | 2022 | 163.98% |
Akero Therapeutics (AKRO) | 2022 | 157.64% |
Belite Bio Inc ADR (BLTE) | 2022 | 141.16% |
Biohaven Pharmaceutical (BHVN) | 2022 | 131.33% |
Helmerich and Payne (HP) | 2022 | 113.06% |
CVR Energy (CVI) | 2022 | 113% |
Immunovant (IMVT) | 2022 | 107.36% |
Axsome Therapeutics (AXSM) | 2022 | 103.35% |
Patterson-UTI Energy (PTEN) | 2022 | 101.74% |
Vaxcyte (PCVX) | 2022 | 101.47% |
Viking Therapeutics (VKTX) | 2022 | 101.28% |
F&G Annuities & Life (FG) | 2022 | 100.1% |
Modine Manufacturing (MOD) | 2022 | 94.13% |
Allegheny Technologies (ATI) | 2022 | 86.39% |
Valaris (VAL) | 2022 | 86.28% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
